Result of oral intake of glucose by healthy subjects and patients with essential hypertension on the binding and degradation of 125I-insulin by erythrocyte receptors

Journal of Physiology and Pharmacology

Volumn 47, Issue 2, 1996, Pages 269-279

  Szczesniak, L ^a   Rychlewski, T ^b   Gluszek, J ^a   Michocki, P ^b   Banaszak, F ^a  

^a POZNAN UNIVERSITY OF PHYSICAL EDUCATION   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Essential hypertension; Insulin binding and degradation; Insulin receptor; OGTT

Indexed keywords

GLUCOSE; INSULIN I 125; INSULIN RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DEGRADATION; ERYTHROCYTE; ESSENTIAL HYPERTENSION; FOOD DEPRIVATION; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; HUMAN; INSULIN BINDING; INSULIN BLOOD LEVEL; ORAL GLUCOSE TOLERANCE TEST; RECEPTOR BINDING; SITTING; TECHNIQUE;

ADMINISTRATION, ORAL; ADULT; ERYTHROCYTES; FEMALE; GLUCOSE; HUMANS; HYPERINSULINISM; HYPERTENSION; INSULIN; MALE; MIDDLE AGED; RECEPTOR, INSULIN;

EID: 0029682006     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Welborn TA, Breckenridge A, Rubinstein AH et al. Serum insulin in essential hypertension and in peripheral vascular disease. Lancet 1966; 1: 1336-1337.
2. Modan M, Halkin H, Almog S et al. Hyperinsulinemia. A link between hypertension, obesity and glucose intolerance. J Clin Invest 1985; 75: 809-817.
3. Ferrannini E, Burrigoli G, Bonadonna R et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357.
4. Shen DC, Shieh SM, Fuk M M-T et al. Resistance to insulin stimulated -glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988; 66: 580-583.
5. Constable SH, Favier RJ, Cariée GD et al. Muscle glucose transport: interactions of in vitro contractions insulin and exercise. J Appl Physiol 1988; 64: 2329-2332.
6. Gambhir KK, Archer JA, Certer L. Insulin radioreceptor assay for human erythrocytes. Clin Chem 1977; 23: 1590-1595.
7. Reaven GM. Role in insulin in human disease. Diabetes 1988; 37: 1595-1607.
8. Ferrannini E, Haffner SM, Stern M. Essential hypertension a insulin-resistance state. J Cardiorasc Pharmacol 1990; 15 (Suppl. 5): 18-25.
9. Gluszek J, Szczçsniak L, Banaszak F et al. A. Insulin binding and its degradation by erythrocytes of nonobese patients with essential hypertension, (in press).
10. Gluszek J, Banaszak F, Szczçsniak L et al. Insulin concentration in the blood of patients with essential hypertension. Non-iny Lekarskie 1991; 2: 92-96.
11. Nilson PM, Lindholm LH, Schersten BF. Life style changes improve insulin resistance in hyperinsulinemia subjects: a one-year intervention study of hypertensives and normotensives in Dalby. J Hypertension 1992; 10: 1071-1078.
12. Reaven GM. The role in insulin resistance and hyperinsulinemia in coronary heart disease. Metabolism 1992; 41: 16-22.
13. Lindhai B, Asplund K, Halmas G. High serum, insulin resistance and theit associations with cardiovascular risk factors. The Northen Sweden MONICA population study. J Int Med 1993; 234: 263-267.
14. Clauser E, Lecomte I, Auzan C. Molecular basis of insulin resistance. Harm Res 1992; 38; 5-12.
15. Nadiv O, Cohen O, Zick Y. Defects in insulins signal transduction in old rat livers. Endocrinology 1992; 130: 1515-1524.
16. De Fronzo RA. Glucose intolerance and aging. Evidence for tissue insensitivity to insulin. Diabetes 1979; 28: 1095-1101.
17. Chen M, Bergman RN, Pacini G. Pathogenesis of age -related glucose and responsiveness to insulin in forearm muscle. J Am Geriatr Soc 1980; 28: 304-307.
18. Soman VR, Koivisto VA, Grandham P et al. Increased insulin binding to monocytes after acute exercise in normal man. J Clin Endocrinol Metab 1978; 47: 216-219.
19. Sanchez-Margalet V, Valle M, Labon JA et al. Diminished insulin receptors on erythrocyte ghosts in nonobese patients with essential hypertension independent of hyperinsulinemia. J Cardio\-asc Pharmacol 1994; 24: 74-77.